These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32394601)
1. Re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: At which gestational ages should magnesium sulphate be given to women at risk of preterm birth? Larsen ML; Krebs L; Rackauskaite G; Hoei-Hansen CE; Greisen G BJOG; 2020 Sep; 127(10):1295-1296. PubMed ID: 32394601 [No Abstract] [Full Text] [Related]
2. Authors' reply re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: Time range for treatment with magnesium sulphate. Wolf HT; Brok J; Henriksen TB; Hegaard HK; Greisen G; Weber T; Pryds O; Salvig JD; Hedegaard M; Pinborg A; Huusom LD BJOG; 2020 Sep; 127(10):1296-1297. PubMed ID: 32427415 [No Abstract] [Full Text] [Related]
3. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial. Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD; BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024 [TBL] [Abstract][Full Text] [Related]
5. Translating antenatal magnesium sulphate neuroprotection for infants born <28 weeks' gestation into practice: A geographical cohort study. Doyle LW; Spittle AJ; Olsen JE; Kwong A; Boland RA; Lee KJ; Anderson PJ; Cheong JLY; Aust N Z J Obstet Gynaecol; 2021 Aug; 61(4):513-518. PubMed ID: 33528040 [TBL] [Abstract][Full Text] [Related]
6. No. 376-Magnesium Sulphate for Fetal Neuroprotection. Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485 [TBL] [Abstract][Full Text] [Related]
7. Effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The MagNUM Study. Poppe T; Thompson B; Boardman JP; Bastin ME; Alsweiler J; Deib G; Harding JE; Crowther CA; EBioMedicine; 2022 Apr; 78():103923. PubMed ID: 35331677 [TBL] [Abstract][Full Text] [Related]
8. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Doyle LW; Crowther CA; Middleton P; Marret S Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771 [TBL] [Abstract][Full Text] [Related]
9. Magnesium sulphate for prevention of cerebral palsy: if not now, when? Grobman WA BJOG; 2020 Sep; 127(10):1226. PubMed ID: 32339385 [No Abstract] [Full Text] [Related]
10. [Neuroprotection for preterm infants with antenatal magnesium sulphate]. Marret S; Ancel PY J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926 [TBL] [Abstract][Full Text] [Related]
12. Magnesium sulphate for women at term for neuroprotection of the fetus. Nguyen TM; Crowther CA; Wilkinson D; Bain E Cochrane Database Syst Rev; 2013 Feb; (2):CD009395. PubMed ID: 23450601 [TBL] [Abstract][Full Text] [Related]
13. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan. Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232 [TBL] [Abstract][Full Text] [Related]
14. Maternal obesity and neuroprotective magnesium sulfate. McPherson J; Smiley S; Stamilio D Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874 [TBL] [Abstract][Full Text] [Related]
15. Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand - Ongoing barriers and enablers. Gatman K; May R; Crowther C Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):44-48. PubMed ID: 31119725 [TBL] [Abstract][Full Text] [Related]
16. Prenatal Magnesium Sulfate and Functional Connectivity in Offspring at Term-Equivalent Age. Ufkes S; Kennedy E; Poppe T; Miller SP; Thompson B; Guo J; Harding JE; Crowther CA JAMA Netw Open; 2024 May; 7(5):e2413508. PubMed ID: 38805222 [TBL] [Abstract][Full Text] [Related]
17. Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women's and Children's Hospital, Adelaide 2010-2013. Siwicki K; Bain E; Bubner T; Ashwood P; Middleton P; Crowther CA Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):233-8. PubMed ID: 26084194 [TBL] [Abstract][Full Text] [Related]
18. Antenatal magnesium for preterm delivery reduces risk of cerebral palsy among surviving very preterm infants. Paulsen ME; Dietz RM Acta Paediatr; 2018 Jan; 107(1):175. PubMed ID: 29083069 [No Abstract] [Full Text] [Related]
19. Antenatal magnesium sulphate neuroprotection in the preterm infant. Marret S; Doyle LW; Crowther CA; Middleton P Semin Fetal Neonatal Med; 2007 Aug; 12(4):311-7. PubMed ID: 17513184 [TBL] [Abstract][Full Text] [Related]
20. Protection of brain development by antenatal magnesium sulphate for infants born preterm. Chollat C; Sentilhes L; Marret S Dev Med Child Neurol; 2019 Jan; 61(1):25-30. PubMed ID: 30294845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]